ND
Navin Deshlahra
About Navin Deshlahra
Data last updated:
Navin Deshlahra is a Director at Aspire Pharmaceuticals Private Limited (since 2023) and Designated Partner at Safe-W Pharma Llp (since 2026). The companies operate in Pharma and Engineering. The largest current company by reported revenue is Aspire Pharmaceuticals Private Limited at ₹2.5 Lakh (FY 2025). Earlier, Navin Deshlahra was a Director at Core Fab Projects (Unit-Ii) Private Limited (2004–2008).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aspire Pharmaceuticals Private Limited U24110CT2020PTC010922 | Director | 01 Mar 2023 | 2020 | ₹2.5 Lakh (FY 2025) | Active |
| Safe-W Pharma Llp ADA-4847 | Designated Partner | 27 Jul 2026 | 2026 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Core Fab Projects (Unit-Ii) Private Limited U27104CT2004PTC017006 | Director | 01 Oct 2004 | 2004 | ₹2.25 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Navin Deshlahra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashish Chopda | 00903764 | Aspire Pharmaceuticals Private Limited | Director |
| Rishabh Chopda | 00923464 | Aspire Pharmaceuticals Private Limited | Director |
| Usha Sharma | 10056482 | Aspire Pharmaceuticals Private Limited | Director |
| Yamini Nirmal Maheshwari | Aspire Pharmaceuticals Private Limited | Company Secretary | |
| Chaitanya Kumar Sahu | 11852285 | Safe-W Pharma Llp | Designated Partner |
| Dharmendra Kumar Patel | 11852284 | Safe-W Pharma Llp | Designated Partner |
| Rahul Yadu | 11852282 | Safe-W Pharma Llp | Designated Partner |
| Rajendra Kumar Sahu | 11852286 | Safe-W Pharma Llp | Designated Partner |
| Vivek Kumar Jain | 11852283 | Safe-W Pharma Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navin Deshlahra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navin Deshlahra
Navin Deshlahra currently holds 2 directorships: Aspire Pharmaceuticals Private Limited (Director, since 01 Mar 2023, revenue ₹2.5 Lakh (FY 2025)); Safe-W Pharma Llp (Designated Partner, since 27 Jul 2026).
Navin Deshlahra was first appointed on 01 Oct 2004 as Director at Core Fab Projects (Unit-Ii) Private Limited. The most recent appointment on record is 27 Jul 2026 at Safe-W Pharma Llp.
Navin Deshlahra held 1 earlier board appointment: Core Fab Projects (Unit-Ii) Private Limited (Director, 01 Oct 2004 to 23 Sep 2008).
The current boards of Navin Deshlahra's companies include Ashish Chopda (Aspire Pharmaceuticals Private Limited), Rishabh Chopda (Aspire Pharmaceuticals Private Limited), Usha Sharma (Aspire Pharmaceuticals Private Limited), Yamini Nirmal Maheshwari (Aspire Pharmaceuticals Private Limited), Chaitanya Kumar Sahu (Safe-W Pharma Llp), Dharmendra Kumar Patel (Safe-W Pharma Llp), among others.